$CL

COLGATE PALMOLIVE CO

CIK:0000021665|SEC Filings

Condensed Consolidated Statements of Income - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Jun. 30, 2026	Jun. 30, 2025	Jun. 30, 2026	Jun. 30, 2025
Income Statement [Abstract]
Net sales	$ 5,361	$ 5,110	$ 10,686	$ 10,021
Cost of sales	2,065	2,041	4,164	3,965
Gross profit	3,296	3,069	6,522	6,056
Selling, general and administrative expenses	2,130	1,963	4,206	3,861
Other (income) expense, net	150	26	336	39
Operating profit	1,016	1,080	1,980	2,156
Non-service related postretirement costs	21	23	47	95
Interest expense	62	71	124	137
Interest income	17	21	33	35
Income before income taxes	950	1,007	1,842	1,959
Provision for income taxes	231	234	441	460
Net income including noncontrolling interests	719	773	1,401	1,499
Less: Net income attributable to noncontrolling interests	26	30	62	66
Net income attributable to Colgate-Palmolive Company	$ 693	$ 743	$ 1,339	$ 1,433
Earnings per common share, basic (in dollars per share)	$ 0.87	$ 0.92	$ 1.67	$ 1.77
Earnings per common share, diluted (in dollars per share)	$ 0.86	$ 0.91	$ 1.67	$ 1.76

Condensed Consolidated Statements of Cash Flows - USD ($) $ in Millions	6 Months Ended
	Jun. 30, 2026	Jun. 30, 2025
Operating Activities
Net income including noncontrolling interests	$ 1,401	$ 1,499
Adjustments to reconcile net income including noncontrolling interests to net cash provided by operations:
Depreciation and amortization	311	299
ERISA litigation matter	0	65
Restructuring and termination benefits, net of cash	232	(13)
Stock-based compensation expense	78	55
Deferred income taxes	(15)	(17)
Cash effects of changes in:
Receivables	(274)	(152)
Inventories	(110)	3
Accounts payable and other working capital	124	(248)
Other non-current assets	47	31
Other non-current liabilities	(52)	(38)
Net cash provided by (used in) operations	1,742	1,484
Investing Activities
Capital expenditures	(266)	(232)
Purchases of marketable securities and investments	(124)	(384)
Proceeds from sale of marketable securities and investments	150	350
Payment for acquisition, net of cash acquired	0	(293)
Other investing activities	(4)	(1)
Net cash provided by (used in) investing activities	(244)	(560)
Financing Activities
Short-term borrowing (repayment) less than 90 days, net	1,053	(30)
Principal payments of debt	(1,086)	(139)
Proceeds from issuance of debt	0	497
Dividends paid	(879)	(880)
Purchases of treasury shares	(597)	(516)
Proceeds from exercise of stock options	138	65
Other financing activities	(43)	136
Net cash provided by (used in) financing activities	(1,414)	(867)
Effect of exchange rate changes on Cash and cash equivalents	(2)	62
Net increase (decrease) in Cash and cash equivalents	82	119
Cash and cash equivalents at beginning of the period	1,288	1,096
Cash and cash equivalents at end of the period	1,370	1,215
Supplemental Cash Flow Information
Income taxes paid	459	530
Interest paid	$ 127	$ 137

Condensed Consolidated Balance Sheets - USD ($) $ in Millions	Jun. 30, 2026	Dec. 31, 2025
Current Assets
Cash and cash equivalents	$ 1,370	$ 1,288
Receivables (net of allowances of $91 and $90, respectively)	1,962	1,675
Inventories	2,181	2,032
Other current assets	795	714
Total current assets	6,308	5,709
Property, plant and equipment:
Cost	11,020	10,856
Less: Accumulated depreciation	(6,381)	(6,196)
Property, plant and equipment, net	4,639	4,660
Goodwill	3,100	3,122
Other intangible assets, net	1,495	1,536
Deferred income taxes	221	205
Other assets	1,027	1,098
Total assets	16,790	16,330
Current Liabilities
Debt payable within one-year	34	1,117
Accounts payable	2,115	2,089
Accrued income taxes	410	383
Other accruals	3,589	3,264
Total current liabilities	6,148	6,853
Long-term debt	7,823	6,871
Deferred income taxes	201	181
Other liabilities	2,052	2,060
Total liabilities	16,224	15,965
Shareholders’ Equity
Common stock, $1 par value (2,000,000,000 shares authorized, 1,465,706,360 shares issued)	1,466	1,466
Additional paid-in capital	4,432	4,322
Retained earnings	27,085	26,595
Accumulated other comprehensive income (loss)	(3,816)	(3,879)
Treasury stock, at cost	(28,931)	(28,450)
Total Colgate-Palmolive Company shareholders’ equity	236	54
Noncontrolling interests	330	311
Total equity	566	365
Total liabilities and equity	$ 16,790	$ 16,330